The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
You reckon they will go into specifics around sales figures as the sales data ultimately belongs to their distribution partners ? Bit hard to present at an investors seminar and not share specifics around sales progress to date (numbers)
I tried you method and it reports 100 + purchased in the last 24 hours
Good one Mannix for that useful bit of info and thanks to those sharing info from various sources
What you do with that approval and how you take your product to the market and generate revenue is of course fundamental but I still did expect for the SP to rise higher yesterday
I think a lot of people on here do understand that these things take time to gain traction , distribution sales, marketing , partnering , manufacturing , planning , GTM strategies for different markets. But lets be honest here , we all were expecting a much bigger rise off the back of the FDA approval. That is a pretty big deal or hurdle to overcome .
Yes i also expected a much bigger rise tbh after such a long wait . The market is a funny ol thing and expected the rise to be larger than the EU approval. However on the plus side at least we have the approval now for commercialisation bidding allowed to fully take place in the US and we could all have been in a different position this morning had they not got the approval so i like to see the positives . My strategy has always been a long term view and i am her to stay as the company builds momentum globally
Agree, well done to James Barder and team for getting the FDA approval and congratulations to my fellow long term FUMSTERS!!
Keep the spirits up guys , we have been patient for this long ! Hoping for the US FDA approval to come soon , but at least in the meantime we have tangible product we can touch and on the market in distribution. I see negative reviews on Boots website and a lot of them end with "will stick to Viagra" which i find slightly interesting, it could just be the sceptic in me
Good post 81Lucky , puts things into perspective .
What is it going to take James Barder to have a Cheshire cat smile on these podcasts i wonder.? He still likes to hold his cards very much close to his chest and not get the market overexcited as always .
Big expectations from this stock next year , been in this for far too long
We understand that the motive for acquiring a GP services company was part of another route to market play to propagate cannabis treatments as well . Was this also an investment to diversify into the services sector as well , this is what has left me scratching my head also as the online health services sector will only grow accelerated by the pandemic having a knock on effect on the NHS.
I would also concur with this , remember this share price moved up to around£1 back in the early days and we should take comfort that LO are fully invested in this for the long play and have not been deterred by the slow progress made as they expect a much bigger reward. the trial success was the de-risker for the product and allows FUM to go into any deals with confidence that they have a product that is verified independently
Wonderful news today and the results seem very positive to back up previous studies and now de risk the product for a clear path ahead for FDA authorisation in Q1 2023. fingers crossed. I was expecting a bigger jump in share price based off this news if i am perfectly honest , but that just could be short term holders selling for small profit. Anyway for LTH the future looks bright from here on now finally after all those years and expect a gradual increase of SP over the next 6 -12
Can someone remind me why Hellenic/CBX stated that they were growing in Greece, i was trying to remember and not in the UK again?
FYI
Looks like the cannabis party is just getting started in the UK to me
https://www.constructionenquirer.com/2022/06/28/peel-submits-plan-for-150m-cannabis-production-complex/
Came across this article today and thought I share here:
https://www.bbc.co.uk/news/world-middle-east-61803199
Also , i went Turkey recently and found it interesting how a lot of the shops sold sexual performance enhancement products including a lot of the herbs and spices shops and markets
well whatever side of the fence we are on , we agree on one thing that this will impact the share price and investor sentiment . Everything was gearing up to to a very busy period in the summer for aviation and holiday companies , a much needed boost , this will need to get resolved either way before then hopefully
Never been a fan of unions unfortunately, I have some sympathy with workers , but when they choose to do it at a time families have been desperate to get away after 2 years of the pandemic which bought job loss and loss of income and death of loved ones , my sympathy runs out. Having a job in this climate is a privilege and should be abused. I always say if you are not happy with your job always vote with your feet and move on
All the below comments below are a reflection of the communication and holding off of the BOD to launch, hence why we all are speculating . Had FUM been clear in their comms on launch timelines then we would not need to speculate and come up with our own theories. Fuzzy wuzzy comms by barder and co does not give certainty to the market
Are we launching in the UK before the FDA submission ?
Are we waiting for FDA submission first?
My understanding was launch in the EU will be in the next 10 months?
Thanks for that , so having given it some thought , the sales launches will happen post FDA submission and thumbs up from FDA as that will de risk the product for longer term usage by users (which was one of the test criteria for FM71) and then allow for a full product launch with confidence into the various regions